SCHEMBL4967889

SCHEMBL4967889

COc1ccccc1NC1CCCc2c1[nH]c1ccc(Br)cc21.Clc1ccccc1NC1CCCc2c1[nH]c1ccc(Br)cc21

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.62
KCNH2 Q12809 1/20 0.55
DHODH Q02127 2/20 0.46
MAPT P10636 4/20 0.43
ALOX15 P16050 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
GLA P06280 1/20 0.43
KMT2A Q03164 1/20 0.43
HTR2A P28223 3/20 0.43
HTR2C P28335 3/20 0.43
BRD3 Q15059 1/20 0.42
MAPK1 P28482 1/20 0.42
CDC42 P60953 1/20 0.41
RB1 P06400 4/20 0.40
GAA P10253 1/20 0.40
CASP6 P55212 1/20 0.40
THRB P10828 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150690 0.94 CYP2D6 (0.69) CYP2D6KCNH2DHODHMAPTALOX15
SCHEMBL4152266 0.91 CYP2D6 (0.73) CYP2D6KCNH2DHODHMAPTALOX15
SCHEMBL22135764 0.79 CYP2D6 (0.59) CYP2D6KCNH2DHODHMAPTKMT2A
SCHEMBL22135737 0.79 CYP2D6 (0.59) CYP2D6KCNH2DHODHMAPTKMT2A
SCHEMBL4142995 0.79 CYP2D6 (0.73) CYP2D6KCNH2DHODHMAPTALOX15
SCHEMBL4142710 0.79 CYP2D6 (0.73) CYP2D6KCNH2DHODHMAPTALOX15
SCHEMBL4024328 0.77 CYP2D6 (0.57) CYP2D6KCNH2DHODHMAPTALOX15
SCHEMBL4139855 0.77 CYP2D6 (1.00) CYP2D6KCNH2DHODHMAPTALOX15
SCHEMBL4150973 0.77 CYP2D6 (0.74) CYP2D6KCNH2DHODHMAPTALOX15
Hydrochloric Acid SCHEMBL4137980 0.76 CYP2D6 (0.98) CYP2D6KCNH2DHODHMAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654228-B1 TETRAHYDROCARBAZOLE DERIVATIVES AND THEIR PHARMACEUTICAL USE SMITHKLINE BEECHAM CORP (US) 2008-10-22 EP disclosed